Skip to search boxSkip to navigationSkip to main content

Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project

  • the Classification Criteria for Anti-Synthetase Syndrome Project participating investigators
    ,
  • Sara Faghihi-Kashani
    ,
  • Akira Yoshida
    ,
  • Francisca Bozan
    ,
  • Giovanni Zanframundo
    ,
  • Davide Rozza
  • University of Pittsburgh
    ,
  • Nippon Medical School
    ,
  • Universidad de Chile
    ,
  • IRCCS Fondazione Policlinico San Matteo - Pavia
    ,
  • Italian Society of Rheumatology
    ,
  • University of Bath
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Abstract

Objective: Anti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data-driven classification criteria for ASSD. Methods: We used a large, international, multicenter “Classification Criteria for Anti-synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort. Results: Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo-1 and non–Jo-1 anti-synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti-Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD. Conclusion: We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data-driven classification criteria for ASSD. (Figure presented.).

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 477-489 (13 pages)

Journal (Volume, Issue Number)

Arthritis and Rheumatology (Volume 77, Issue 4)

Publication milestones

  • Accepted/In press - 2024
  • Published - 04/2025

Publication status

Published - 04/2025

ISSN

2326-5191

Publication IDs

  • Scopus: 85212698290
  • PubMed: 39467037

Publication metrics

Metrics

Fractional count
1
Fractional count
0.02
Fractional count
49
Fractional count
0.98
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
38
Captures
25

Funding Details

Supported by the American College of Rheumatology, EULAR, and Intramural Research Program project ZIA‐ES101081 of the National Institute of Environmental Health Sciences, NIH.
FundersFunding number
American College of Rheumatology
-
NIH
-
NIEHS
-
EULAR
ZIA‐ES101081